Results 181 to 190 of about 644,115 (313)

Design, Synthesis, and Biological Activity of Novel Factor Xa Inhibitors: 4-Aryloxy Substituents of 2,6-Diphenoxypyridines††See ref. 1.

, 2002
Howard P. Ng, Brad O. Buckman, Keith Eagen, William J. Guilford, Monica J. Kochanny, Raju Mohan, Kenneth J. Shaw, Shung Wu, Dao Lentz, Amy Liang, Lan Trinh, Elena Ho, David F. Smith, Babu Subramanyam, Ron Vergona, Janette Walters, Kathy White, Mark Sullivan, Michael M. Morrissey, Gary B. Phillips   +19 more
openalex   +1 more source

Treatment of Proximal Deep-Vein Thrombosis with the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients with Acute Symptomatic Deep-Vein Thrombosis) Study [PDF]

, 2008
G. Agnelli, A. Gallus, S.Z. Goldhaber
openalex   +1 more source

The efficacy and safety of direct factor Xa inhibitors versus vitamin K antagonists for atrial fibrillation in patients on hemodialysis: a meta-analysis of randomized controlled trials. [PDF]

Proc (Bayl Univ Med Cent), 2023
Abuelazm M, Mahmoud A, Ali S, Gamal M, Elmezayen A, A Elzeftawy M, Abdelazeem B.   +6 more
europepmc   +1 more source

Construction and In Vitro Testing of a Novel Fab-Hirudin–Based Fusion Protein That Targets Fibrin and Inhibits Thrombin in a Factor Xa–Dependent Manner

, 2003
Karlheinz Peter, Amitabh Gupta, Thomas K. Nordt, Simone Bauer, Marschall S. Runge, Christoph Bode   +5 more
openalex   +1 more source

Pitfalls in Argatroban Monitoring: Heparin Interference With Dilute Thrombin Time Assays

International Journal of Laboratory Hematology, Volume 47, Issue 5, Page 989-991, October 2025.
Agathe Herb, Jordan Wimmer, Laurent Mauvieux, Laurent Sattler   +3 more
wiley   +1 more source

Impact of Factor Xa inhibitors on cardiovascular events in older patients with nonvalvular atrial fibrillation. [PDF]

Aging (Albany NY)
Takahashi M, Morimoto T, Tsushima R, Sudo Y, Sakamoto A, Sogo M, Ozaki M, Okawa K.   +7 more
europepmc   +1 more source

Characteristics of the hemostatic action of KFA-1411, an inhibitor of coagulation factor Xa (FXa), in humans and various animals.

, 2003
Kiyoto Hara, Toshiki Honma, Akane Matsuzawa, Atsushi Matsuzawa, Masahiko Uchida, Takashi Koizumi, Satoshi Akahane, Masami Kojima   +7 more
openalex   +2 more sources

Endovascular Stenting and Factor Xa Inhibitors for Filter-Associated Chronic IVC Occlusion: A Case Series. [PDF]

Am J Case Rep
Cao P, Luo X, Gao R, Li Y, Li L, Zhang Y, Liu X.   +6 more
europepmc   +1 more source

Adverse Events of Factor Xa Inhibitors in Pediatric Patients: A Meta-analysis and Pharmacovigilance Study. [PDF]

Paediatr Drugs
Chong S, Sun L, Mu G, Hua M, Xiang Q, Cui Y.   +5 more
europepmc   +1 more source

Effect of the frequently used antiepileptic drugs carbamazepine, gabapentin, and pregabalin on the pharmacokinetics of edoxaban and other oral factor xa inhibitors in healthy volunteers. [PDF]

Front Pharmacol
Lenard A, Hermann SA, Stoll F, Burhenne J, Foerster KI, Czock D, Mikus G, Meid AD, Haefeli WE, Blank A.   +9 more
europepmc   +1 more source